Skip to main content
. 2015 Nov 6;10:1825–1837. doi: 10.2147/CIA.S93819

Figure 3.

Figure 3

Oral B401 treatment enhances motor ability of R6/2 (HD) mice.

Notes: (A) Gait analysis of 10-week-old R6/2 mice given the oral B401 and sham treatments. (B) Averaged stride lengths of paw placement records of the 10-week-old R6/2 mice given the oral B401 treatment were significantly better than those given the sham treatment. The number of R6/2 mice under oral B401 and sham treatments were eight for each group. Values are mean ± SEM (**P<0.01, one-way ANOVA followed by a Student–Newman–Keuls multiple comparisons posttest).

Abbreviations: HD, Huntington’s disease; ANOVA, analysis of variance; SEM, standard error of the mean.